|
Revenue
|
|
$52.1m
|
$75.5m
|
$107.1m
|
$189.5m
|
$297.7m
|
$337.4m
|
$361.4m
|
$391.5m
|
$430.9m
|
|
Cost of revenue
|
|
$13.4m
|
$15.6m
|
$22.2m
|
$33.2m
|
$51.7m
|
$65.9m
|
$61.8m
|
$70.6m
|
$79.4m
|
|
Gross profit
|
|
$38.8m
|
$59.9m
|
$84.8m
|
$156.3m
|
$245.9m
|
$271.4m
|
$299.5m
|
$320.9m
|
$351.5m
|
|
Research and development
|
|
$16.1m
|
$26.0m
|
$34.5m
|
$45.7m
|
$79.3m
|
$92.6m
|
$90.7m
|
$90.2m
|
$90.7m
|
|
Total operating expenses
|
|
$58.3m
|
$96.4m
|
$119.6m
|
$168.1m
|
$291.3m
|
$346.0m
|
$314.6m
|
$336.7m
|
$352.7m
|
|
Sales and marketing
|
|
$33.8m
|
$49.7m
|
$62.8m
|
$94.4m
|
$159.4m
|
$174.6m
|
$161.2m
|
$171.7m
|
$176.7m
|
|
General and administrative
|
|
$8.4m
|
$20.6m
|
$22.4m
|
$28.0m
|
$52.6m
|
$51.2m
|
$62.7m
|
$74.8m
|
$85.3m
|
|
Operating loss
|
|
($19.5m)
|
($36.5m)
|
($34.8m)
|
($11.8m)
|
($45.3m)
|
($74.5m)
|
($15.1m)
|
($15.8m)
|
($1.2m)
|
|
Financial income and other, net
|
|
$493k
|
$408k
|
$1.4m
|
($2.8m)
|
($19.5m)
|
$3.6m
|
$20.2m
|
$27.7m
|
$24.6m
|
|
Tax benefit (taxes on income)
|
|
($294k)
|
—
|
($160k)
|
($200k)
|
($159k)
|
($577k)
|
($1.4m)
|
$6.4m
|
($2.4m)
|
|
Net loss attributable to ordinary shareholders
|
|
—
|
($36.1m)
|
($34.2m)
|
($14.8m)
|
($65.0m)
|
—
|
—
|
—
|
—
|
|
Income before taxes on income
|
|
($19.0m)
|
($36.1m)
|
($33.4m)
|
($14.6m)
|
($64.9m)
|
($70.9m)
|
$5.1m
|
$11.9m
|
$23.4m
|
|
Net Income
|
|
($19.3m)
|
($36.1m)
|
($33.5m)
|
($14.8m)
|
($65.0m)
|
($71.5m)
|
$3.7m
|
$18.2m
|
$21.0m
|
|
Basic net income per share attributable to ordinary shareholders
|
|
—
|
—
|
—
|
($0)
|
($2)
|
($2)
|
$0
|
$0
|
$1
|
|
Diluted net income per share attributable to ordinary shareholders
|
|
($3)
|
($5)
|
($2)
|
($0)
|
($2)
|
($2)
|
$0
|
$0
|
$1
|
|
Basic weighted average ordinary shares
|
|
—
|
—
|
—
|
$32.3m
|
$36.0m
|
$36.9m
|
$38.1m
|
$37.0m
|
$36.3m
|
|
Diluted weighted average ordinary shares
|
|
—
|
—
|
—
|
$32.3m
|
$36.0m
|
$36.9m
|
$39.2m
|
$37.8m
|
$37.2m
|